A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to…

Overview of attention for article published in Supportive Care in Cancer, October 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,641 followers.

A Phase II/III Study to Determine Dose & Safety of Pegteograstim Compared to Pegfilgrastim in #BreastCancer @SNUNow http://t.co/ehKfjgmtdR

Reply Repost Favourite

A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the… http://t.co/RUNfMMVzTN #breastcancer

Reply Repost Favourite